Septerna (SEPN) Deferred Taxes (2024)

Septerna (SEPN) recorded quarterly Deferred Taxes of -$153000.0 in Q4 2024, down 12.5% quarter-over-quarter from -$136000.0 in Q3 2024.

Septerna (SEPN) Deferred Taxes (2024) Analysis & Trends

Septerna's Deferred Taxes history runs 1 years deep, the most recent figure standing at -$153000.0 for Q4 2024.

In Q4 2024, Deferred Taxes changed N/A year-over-year to -$153000.0; the TTM figure through Dec 2024 stood at -$491000.0 (changed N/A YoY), while the FY2024 annual figure was -$491000.0, down 200.0% from the prior year.
Deferred Taxes was -$153000.0 for Q4 2024 at Septerna, down from -$136000.0 in the prior quarter.
In the past five years, Deferred Taxes ranged from a high of -$93000.0 in Q1 2024 to a low of -$153000.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Deferred Taxes (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-859,000.00
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-65.30 Mn
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Septerna	1.62 Bn	1.62 Bn	-	-

Download Data